Digital SparkRx: The first digital therapeutic for adolescents Mental health issues among teens and young adults have risen dramatically over the past decade.
News Limbix' digital therapeutic cuts depression symptoms in youn... Limbix is moving ahead with plans to file for FDA approval of its SparkRx digital therapeutic (DTx) for adolescents with symptoms of depression after reporting positive results in a clinica
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
